Skip to main content
CVS addressing patient concerns about value-based drug plan
10/4/2019

CVS Health did a soft rollout of its new pharmacy benefit plan that bases coverage of some drugs on cost-benefit analyses by the Institute for Clinical and Economic Review, and the company is working with patient advocacy groups before promoting the plan more widely, Chief Medical Officer Troy Brennan says.

Full Story: